For the quarter ended December 2025, Corteva, Inc. (CTVA) reported revenue of $3.91 billion, down 1.7% over the same period last year. EPS came in at $0.22, compared to $0.32 in the year-ago quarter.
The reported revenue represents a surprise of -7.49% over the Zacks Consensus Estimate of $4.23 billion. With the consensus EPS estimate being $0.21, the EPS surprise was +3.14%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Crop Protection: $2.17 billion compared to the $2.41 billion average estimate based on four analysts. The reported number represents a change of -1.5% year over year.
- Revenue- Seed: $1.74 billion versus the four-analyst average estimate of $1.82 billion. The reported number represents a year-over-year change of -2%.
- Revenue- Seed- Other oilseeds: $94 million versus $89.86 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.1% change.
- Revenue- Crop Protection- Biologicals: $191 million versus the two-analyst average estimate of $186.79 million.
- Revenue- Crop Protection- Herbicides: $1.06 billion versus $1.14 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3% change.
- Revenue- Crop Protection- Insecticides: $488 million compared to the $557.11 million average estimate based on two analysts. The reported number represents a change of -0.4% year over year.
- Revenue- Crop Protection- Fungicides: $272 million versus the two-analyst average estimate of $357.43 million. The reported number represents a year-over-year change of -15%.
- Revenue- Crop Protection- Other: $160 million versus the two-analyst average estimate of $213.87 million. The reported number represents a year-over-year change of -18.4%.
- Revenue- Seed- Soybean: $164 million compared to the $155.13 million average estimate based on two analysts. The reported number represents a change of +6.5% year over year.
- Revenue- Seed- Corn: $1.39 billion versus $1.41 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
- Revenue- Seed- Other: $93 million compared to the $138.89 million average estimate based on two analysts. The reported number represents a change of -22.5% year over year.
- Operating EBITDA- Seed: $124 million compared to the $103.5 million average estimate based on three analysts.
View all Key Company Metrics for Corteva, Inc. here>>>
Shares of Corteva, Inc. have returned +7.9% over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Corteva, Inc. (CTVA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
